Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 2

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Tabassum (Taby) Ahsan, Ph.D.
Expertise: Biomedical Engineering
Term: 05/17/2021-03/31/2024
Vice President
Cell Therapy Operations
City of Hope
Duarte, CA 91010

Marshall E. Bloom, M.D.
Expertise: Virology Viral Vectors and Gene Therapies
Term: 04/01/2022-03/31/2026
Division of Intramural Research
Chief, Biology of Vector-Borne Viruses Section
Laboratory of Virology
Rocky Mountain Laboratories
National Institutes of Allergy and Infectious Diseases
National Institutes of Health
Hamilton, MT 59840

Christopher K. Breuer, M.D.
Expertise: General Surgery and Pediatric Surgery
Term: 06/07/2018–03/31/2026
Director of Tissue Engineering Program and Surgical Research
Director, Center for Regenerative Medicine
Nationwide Children’s Hospital
Columbus, OH 43215

Eric Crombez, M.D. *
Expertise: Industry Representative
Term: 09/19/2022-03/31/2024
Chief Medical Officer
Ultragenyx Gene Therapy
Cambridge, MA 02139

Donald B. Kohn, M.D.
Expertise: Gene Therapies for Blood Diseases
Term: 08/23/2022-03/31/2025
Distinguished Professor
Departments of Microbiology, Immunology and Molecular Genetics; Pediatrics; Molecular and Medical Pharmacology
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, CA 90095

Wendy B. London, Ph.D.
Expertise: Biostatistics, Clinical Trial Design, Oncology
Term: 04/01/2023-03/31/2027
Associate Professor of Pediatrics
Boston Children's Hospital/Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA 02215

Sean J. Morrison, Ph.D.
Expertise: Stem Cell Biology
Term: 06/07/2018-03/31/2026
Director
Children’s Medical Center Research Institute
University of Texas Southwestern Medical Center
Dallas, TX 75390

Kathleen O’Sullivan-Fortin, Esq.**
Expertise: Consumer Representative
Term: 08/23/2022–03/31/2025
Founder, ALD Connect, Inc.
Middleton, MA 01949

Melanie Ott, M.D., Ph.D.
Expertise: Virology and Immunology
Term: 04/01/2022-03/31/2026
Gladstone Institute of Virology and Immunology
University of California, San Francisco
San Francisco, CA 94158

Nirali N. Shah M.D., M.H.Sc.
Expertise: Hematology and Oncology
Term: 02/04/2022-03/31/2026
Head, Hematologic Malignancies Section
Pediatric Oncology Branch
Lasker Clinical Research Scholar
National Cancer Institute
Bethesda MD 20892

Gil I. Wolfe, M.D.
Expertise: Neurology
Term: 02/04/2022-03/31/2026
Professor and Chairman of Neurology
Irvin and Rosemary Smith Chair
University at Buffalo Distinguished Professor
Department of Neurology
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/SUNY
Buffalo, NY 14202-1102

Joseph Wu, M.D., Ph.D.
Expertise: Cardiology and Radiology
Term: 4/1/2020-03/31/2025
Director, Stanford Cardiovascular Institute
Professor of Medicine and Radiology
Stanford University
Stanford, CA 94305

* Industry Representative
** Consumer Representative
***Alternate Industry Representative
**** Chairperson

Designated Federal Officer
Marie DeGregorio, B.A.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Phone: (240) 402-4207
E-mail: CTGTAC@fda.hhs.gov

Committee Management Specialist
Tonica Burke, B.S.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Phone: (240) 402-0248
E-mail: CTGTAC@fda.hhs.gov

Director
Prabhakara Atreya, Ph.D.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Phone: (240) 402-8006
E-mail: CTGTAC@fda.hhs.gov

Committee Management Officer
LaShawn Marks
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Phone: (301) 796-0835
E-mail: CTGTAC@fda.hhs.gov